Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P39060 (
endostatin
)
2,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This work describes the application of polarography, a technique scarcely used for modelling and optimisation of stability constants, in the study of copper complexes with [(2-hydroxy-1,1-bis(hydroxymethyl)ethyl)amino]-1-propanesulfonic acid (TAPS). Direct current polarography (DCP), using low total copper ion and large total ligand to total copper concentration, enabled the full characterization of Cu-(TAPS)(x)-(OH)(y) system, whose complexation occurs in the pH range of copper hydrolysis and Cu(OH)(2) precipitation. Cu-(TAPS)(x)-(OH)(y) system was studied by DCP and glass electrode potentiometry (GEP) in aqueous solution at fixed total ligand to total metal concentrations ratios and varied pH values (25.0 degrees C; I=0.1M,
KNO
(3)). The predicted model, as well as the overall stability constants values, are (as logbeta): CuL(+)=4.2, CuL(2)=7.8, CuL(2)(OH)(-)=13.9 and CuL(2)(OH)(2)(2-)=18.94. GEP only allowed confirming the stability constants for CuL(+) and CuL(2) and was used to determine the pK(a) of TAPS, 8.342. Finally, a briefly comparative analysis between TAPS and other structural related buffers was done. Evaluation based on logbeta(CuL) versus pK(a) revealed that TES,
TRIS
, TAPS and AMPSO coordinated via amino and hydroxymethylgroups forming a five-membered chelate ring. For BIS-
TRIS
and TAPSO, and possibly DIPSO, one or more five-membered chelate rings involving additional hydroxyl groups are also likely formed.
...
PMID:Challenges in modelling and optimisation of stability constants in the study of Cu-(TAPS)(x)-(OH)(y) system by polarography. 1907 57